You are here

Syndax

Briggs Morrison’s little biotech Syndax concedes 2 key trial setbacks for its lead drug, as shares shrivel some more

Briggs Morrison’s little biotech Syndax concedes 2 key trial setbacks for its lead drug, as shares shrivel some more

Endpoints

Briggs Morrison

clinical trials

Flag link:

The Week Ahead In Biotech: ASCO Presentations In The Spotlight

The Week Ahead In Biotech: ASCO Presentations In The Spotlight

Yahoo/Benzinga

European Society of Cardiology

Celldex Therapeutics

Jounce Therapeutics

Bristol-Myers Squibb

Flag link:

5 biotech CEOs on payers, investors and big bets

5 biotech CEOs on payers, investors and big bets

BioPharma Dive

Gil Van Bokkelen

DalCor Pharmaceuticals

Pierre Belichard

Michael Metzger

Flag link:

Here are 13 MA cancer biotechs hoping to make waves next month

Here are 13 MA cancer biotechs hoping to make waves next month

Bizjournals.com

Ariad Pharmaceuticals

Vertex Pharmaceuticals

Infinity Pharmaceuticals

Foundation Medicine

Cerulean Pharma

Flag link:

AstraZeneca R&D executive Morrison to lead cancer firm Syndax

AstraZeneca R&D executive Morrison to lead cancer firm Syndax

Yahoo/Reuters

Briggs Morrison

Flag link: